SEC Form 4 · accession 0000899243-16-028700
Invuity, Inc. · IVTY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric W Roberts
Director
Period of report
Sep 6, 2016
Accepted (ET)
Sep 8, 2016 · 5:29 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393020
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Sep 6, 2016 | S | 1,414 | $14.00 | D | 257,833 | I | See footnote |
| Common Stock | holding | — | — | — | 69,945 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold pursuant to the Rule 10b5-1 trading plan entered into by Valence CDK SPV, L.P. ("Valence CDK") on December 1, 2015
- F2The shares are held by Valence CDK. Valence Life Sciences GP II, LLC ("Valence") is the General Partner of Valence CDK. The Reporting Person is a Managing Member of Valence and disclaims beneficial ownership of the shares held by Valence CDK, except to the extent of his pecuniary interest therein.